Skip to content

PRP Use in Treatment of Fistula Ano

Use of Platelet Rich Plasma in Treatment of Perianal Fistula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04187651
Enrollment
100
Registered
2019-12-05
Start date
2019-11-20
Completion date
2026-12-01
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fistula in Ano

Brief summary

In treatment of perianal fistula several methods are described. However, since the Hippocrates basics of surgical treatment has not changed very much. the aim of this study is to evaluate the effectiveness of PRP gel in treatment of perianal fistula.

Detailed description

Perianal fistula is a chronic condition that seriously affects the patients' quality of life. There are different treatment modalities used in treatment. Recently sphincter preserving methods are becoming more popular with low complication rates. Most of this methods aiming the closure of fistula tract by different pathways. Platelet rich plasma (PRP) is used in a wide range of conditions in medicine. The investigator's team showed the effective treatment of pilonidal disease by use of PRP gel. In the recent study, aim to evaluate the effectiveness of PRP gel in treatment of perianal fistula. Patients with perianal fistula will be evaluated for the study. After taking permission with informed consent; cases will be included in the study. Cases with inflammatory bowel disease, platelet function disorders or connective tissue disorders that may alter wound healing will be excluded from the study. After, PRP application to the fistula tract patients will be taken to follow up. Perianal fistulas will be followed by magnetic resonance imaging 1 month after the application. Pre-application and post-application scans will be used for the evaluation of the treatment success.

Interventions

OTHERplatelet rich plasma

platelet rich plasma prepared from the patients' own blood will be applied to the fistula tract

Sponsors

Uşak University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

PRP gel will be applicated to all cases

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with perianal fistula * signing the informed consent form * above the age of 18

Exclusion criteria

* inflammatory bowel disease * previous radiation therapy * having connective tissue disorders

Design outcomes

Primary

MeasureTime frameDescription
percentage of the cure rate1 monthclosure of the fistula tract will be evaluated by physical examination and magnetic resonance imaging

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORBarış Sevinç, M.D.

Uşak University Medical School

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026